Tomasz A Timek1,2, Marcin Malinowski1,3, Robert L Hooker4, Jessica L Parker5, Charles L Willekes1,2, Edward T Murphy1,2, Theodore Boeve1,2, Stephane Leung1,2, Justin S Fanning1,2, John C Heiser1,2. 1. Division of Cardiothoracic Surgery, Spectrum Health, Grand Rapids, MI, USA. 2. Michigan State University College of Human Medicine, Grand Rapids, MI, USA. 3. Department of Cardiac Surgery, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland. 4. Division of Cardiothoracic Surgery, University of South Florida, Tampa, FL, USA. 5. Office of Research, Spectrum Health, Grand Rapids, MI, USA.
Abstract
BACKGROUND: Reductive annuloplasty repair of ischemic mitral regurgitation (IMR) is associated with high rates of recurrent MR, which may be improved with etiology-specific annuloplasty rings. METHODS: From October 2005 to May 2015, 128 consecutive patients underwent repair of IMR with the GeoForm ring. Clinical data was extracted from our local Society of Thoracic Surgeons database and electronic medical records. Mortality data was obtained from the Michigan State Social Security Death Index. RESULTS: The average age of patients was 65±11 years with mean pre-op left ventricular ejection fraction (LVEF) of 30%±10% and MR grade of 3.1±0.9 (0-4+). Thirty-day mortality was 4.7%, rate of renal failure 7.9%, rate of atrial fibrillation 27.3%, and no strokes were observed. Of the surviving patients, 89% (109/122) had a follow-up echocardiogram beyond 1 month with a mean echocardiographic follow-up of 59±39 months. LVEF improved from 30%±10% to 38%±14%, P<0.001) while end-diastolic (5.9±0.0 to 5.3±0.9 cm, P<0.001) and end-systolic (5.0±1.0 to 4.4±1.1 cm, P<0.001) left ventricular (LV) diameters decreased, as compared to pre-operative values. Seven patients were found to have recurrent moderate or greater IMR in follow-up to 10 years with three being due to ring dehiscence. One-, 5-, and 10-year freedom from recurrent moderate or severe IMR was 98%, 94%, and 80% respectively. One-, 5-, and 10-year survival was 91%, 77%, and 44%, respectively. CONCLUSIONS: Overall, etiology-specific ring repair of IMR was associated with low rates of recurrent MR on long-term follow-up, coupled with significant LV reverse remodeling and improvement in ejection fraction. 2021 Annals of Cardiothoracic Surgery. All rights reserved.
BACKGROUND: Reductive annuloplasty repair of ischemic mitral regurgitation (IMR) is associated with high rates of recurrent MR, which may be improved with etiology-specific annuloplasty rings. METHODS: From October 2005 to May 2015, 128 consecutive patients underwent repair of IMR with the GeoForm ring. Clinical data was extracted from our local Society of Thoracic Surgeons database and electronic medical records. Mortality data was obtained from the Michigan State Social Security Death Index. RESULTS: The average age of patients was 65±11 years with mean pre-op left ventricular ejection fraction (LVEF) of 30%±10% and MR grade of 3.1±0.9 (0-4+). Thirty-day mortality was 4.7%, rate of renal failure 7.9%, rate of atrial fibrillation 27.3%, and no strokes were observed. Of the surviving patients, 89% (109/122) had a follow-up echocardiogram beyond 1 month with a mean echocardiographic follow-up of 59±39 months. LVEF improved from 30%±10% to 38%±14%, P<0.001) while end-diastolic (5.9±0.0 to 5.3±0.9 cm, P<0.001) and end-systolic (5.0±1.0 to 4.4±1.1 cm, P<0.001) left ventricular (LV) diameters decreased, as compared to pre-operative values. Seven patients were found to have recurrent moderate or greater IMR in follow-up to 10 years with three being due to ring dehiscence. One-, 5-, and 10-year freedom from recurrent moderate or severe IMR was 98%, 94%, and 80% respectively. One-, 5-, and 10-year survival was 91%, 77%, and 44%, respectively. CONCLUSIONS: Overall, etiology-specific ring repair of IMR was associated with low rates of recurrent MR on long-term follow-up, coupled with significant LV reverse remodeling and improvement in ejection fraction. 2021 Annals of Cardiothoracic Surgery. All rights reserved.
Authors: Wolfgang Bothe; John Peder Escobar Kvitting; Manuel K Rausch; Tomasz A Timek; Julia C Swanson; David H Liang; Mario Walther; Ellen Kuhl; Neil B Ingels; D Craig Miller Journal: J Thorac Cardiovasc Surg Date: 2019-01-11 Impact factor: 5.209
Authors: Paul A Grayburn; Lilin She; Brad J Roberts; Krzysztof S Golba; Krzysztof Mokrzycki; Jaroslaw Drozdz; Alexander Cherniavsky; Roman Przybylski; Krzysztof Wrobel; Federico M Asch; Thomas A Holly; Haissam Haddad; Michael Yii; Gerald Maurer; Irving Kron; Hartzell Schaff; Eric J Velazquez; Jae K Oh Journal: Am J Cardiol Date: 2015-06-25 Impact factor: 2.778
Authors: Tomasz A Timek; Robert L Hooker; Robin Collingwood; Alan T Davis; Craig T Alguire; Charles L Willekes; Edward T Murphy; John C Heiser; Lawrence H Patzelt Journal: J Thorac Cardiovasc Surg Date: 2014-02-21 Impact factor: 5.209
Authors: Salvatore Campisi; Jean F Fuzellier; Benjamain Haber; Jean P Favre; Antoine Gerbay; Marco Vola Journal: Int J Cardiol Date: 2016-08-04 Impact factor: 4.164
Authors: Todd A Armen; Rashmi Vandse; Juan A Crestanello; Subha V Raman; Katherine M Bickle; Nadia S Nathan Journal: Eur J Echocardiogr Date: 2008-05-13
Authors: Daniel Goldstein; Alan J Moskowitz; Annetine C Gelijns; Gorav Ailawadi; Michael K Parides; Louis P Perrault; Judy W Hung; Pierre Voisine; Francois Dagenais; A Marc Gillinov; Vinod Thourani; Michael Argenziano; James S Gammie; Michael Mack; Philippe Demers; Pavan Atluri; Eric A Rose; Karen O'Sullivan; Deborah L Williams; Emilia Bagiella; Robert E Michler; Richard D Weisel; Marissa A Miller; Nancy L Geller; Wendy C Taddei-Peters; Peter K Smith; Ellen Moquete; Jessica R Overbey; Irving L Kron; Patrick T O'Gara; Michael A Acker Journal: N Engl J Med Date: 2015-11-09 Impact factor: 91.245
Authors: Tomislav Mihaljevic; Buu-Khanh Lam; Jeevanantham Rajeswaran; Masami Takagaki; Michael S Lauer; A Marc Gillinov; Eugene H Blackstone; Bruce W Lytle Journal: J Am Coll Cardiol Date: 2007-05-18 Impact factor: 24.094
Authors: Fanwei Kong; Thuy Pham; Caitlin Martin; John Elefteriades; Raymond McKay; Charles Primiano; Wei Sun Journal: PLoS One Date: 2018-06-14 Impact factor: 3.240
Authors: Annabel M Imbrie-Moore; Yuanjia Zhu; Tabitha Bandy-Vizcaino; Matthew H Park; Robert J Wilkerson; Y Joseph Woo Journal: Ann Biomed Eng Date: 2021-11-03 Impact factor: 4.219